3-iodobenzylguanidine has been researched along with Cardiac Hypertrophy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, KF; Enevoldsen, LH | 1 |
| Ito, S; Kawano, T; Koshiba, K; Mikawa, J; Nada, T; Nomura, M | 1 |
| Inoue, K; Katoh, S; Keira, N; Morimoto, S; Satoda, M; Sugihara, H; Takeda, K; Tatsukawa, H; Terada, K | 1 |
| Kurihara, T; Narita, M | 1 |
| Cayla, J; Mardon, K; Merlet, P; Scherrer-Crosbie, M; Syrota, A | 1 |
| Burgess, JH; Chartrand, C; Legault, F; Lepanto, L; Rabinovitch, MA; Rose, CP; Rosenthall, L; Rouleau, JL; Suissa, S; Wieland, DM | 1 |
6 other study(ies) available for 3-iodobenzylguanidine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Sympathetic overactivity in uremia detected by 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Cardiomegaly; Colon; Diagnosis, Differential; Female; Heart; Humans; Hypertension; Liver; Lung; Metanephrine; Pheochromocytoma; Radiography; Radionuclide Imaging; Salivary Glands; Uremia | 2008 |
Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
Topics: 3-Iodobenzylguanidine; Adipokines; Aged; Antihypertensive Agents; Antioxidants; Arteriosclerosis; Autonomic Nervous System; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiomegaly; Carotid Arteries; Catecholamines; Cytokines; Dihydropyridines; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Pulse; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
[A case of hypertensive hypertrophy in which both regression of hypertrophy and improvement of the abnormalities in iodine-123-metaiodobenzylguanidine (MIBG) myocardial imagings were observed after antihypertensive therapy].
Topics: 3-Iodobenzylguanidine; Cardiomegaly; Heart; Humans; Hypertension; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging | 1995 |
[Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Analysis of Variance; Cardiomegaly; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart; Humans; Hypertension; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Sympathetic Nervous System | 1996 |
Alterations of myocardial sympathetic innervation in response to hypoxia.
Topics: 3-Iodobenzylguanidine; Adrenergic Uptake Inhibitors; Altitude Sickness; Animals; Cardiomegaly; Carrier Proteins; Desipramine; Heart; Iodine Radioisotopes; Iodobenzenes; Male; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radionuclide Imaging; Rats; Rats, Wistar; Sympatholytics; Symporters | 1997 |
Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Cardiomegaly; Denervation; Dogs; Heart; Heart Diseases; Iodine Radioisotopes; Iodobenzenes; Neurons; Physical Exertion; Radionuclide Imaging; Sympathetic Nervous System; Sympatholytics | 1987 |